VTI1B, Recombinant, Human, aa1-208, His-Tag (Vesicle Transport Through Interaction with t-SNAREs Homolog 1B, Vesicle Transport v-SNARE Protein Vti1-like 1, Vti1-rp1, VTI1, VTI1L, VTI1L1, VTI2)
Catalog No : USB-045471
508.06€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | VTI1B, Recombinant, Human, aa1-208, His-Tag (Vesicle Transport Through Interaction with t-SNAREs Homolog 1B, Vesicle Transport v-SNARE Protein Vti1-like 1, Vti1-rp1, VTI1, VTI1L, VTI1L1, VTI2) | ||
|---|---|---|---|
| Catalog No | USB-045471 | ||
| Supplier’s Catalog No | 045471 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E.coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 26.3 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | ~85% (SDS-PAGE) | ||
| Form | Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 1mM DTT, 0.15M sodium chloride, 30% glycerol. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | ~85% (SDS-PAGE) | ||
| Description | VTI1B, also known as v-SNARE, mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. Source: Recombinant corresponding to aa1-208 from human VTI1B, fused to His-tag at N-terminus, expressed in E.coli. Molecular Weight: ~26.3kD (231aa) confirmed by MALDI-TOF AA Sequence: MGSSHHHHHH SSGLVPRGSH MGSMASSAAS SEHFEKLHEI FRGLHEDLQG VPERLLGTAG TEEKKKLIRD FDEKQQEANE TLAEMEEELR YAPLSFRNPM MSKLRNYRKD LAKLHREVRS TPLTATPGGR GDMKYGIYAV ENEHMNRLQS QRAMLLQGTE SLNRATQSIE RSHRIATETD QIGSEIIEEL GEQRDQLERT KSRLVNTSEN LSKSRKILRS MSRKVTTNKL L Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
© 2020 Imugex All Rights Reserved